Citation

David M. Margolis, M.D., Lisa Mukherjee, M.S., Courtney V. Fletcher, Pharm.D., Evelyn Hogg, B.A., Debra M. Ogata-Arakaki, R.N., Tianna Petersen, M.S., Dave H. Rusin, M.T. (A.S.C.P.), Ana I. Martinez, R.Ph., John W. Mellors, M.D. The use of [beta]-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infection. AIDS. 2007 Oct 01; 21(15):2025-32.

Citation

Judith Silverstein Currier, M.D., M.Sc., Michelle A. Kendall, M.S., W. Keith Henry, M.D., Beverly L. Alston-Smith, M.D., Francesca J. Torriani, M.D., Pablo Tebas, M.D., Yanjie Li, Howard N. Hodis, M.D. Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults. AIDS. 2007 May 31; 21(9):1137-45.

Citation

Roy (Trip) Gulick, M.D., M.P.H., Christina M. Lalama, M.S., Heather Ribaudo, Ph.D., Cecilia M. Shikuma, M.D., Bruce R. Schackman, Ph.D., Jeffrey T. Schouten, M.D.,J.D., Kathleen E. Squires, M.D., Susan L. Koletar, M.D., Christopher D. Pilcher, M.D., Richard C. Reichman, M.D., Karin L. Klingman, M.D., Daniel R. Kuritzkes, M.D. Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression. AIDS. 2007 Apr 23; 21(7):813-23.

Citation

Scott Evans, Ph.D., Carl J. Fichtenbaum, M.D., Judith A. Aberg, M.D. Comparison of direct and indirect measurement of LDL-C in HIV-infected individuals: ACTG 5087. HIV Clinical Trials. 2007 Jan 01; 8(1):45-52.

Citation

Edward P. Acosta, Pharm.D., Michelle A. Kendall, M.S., John G. Gerber, M.D., Beverly L. Alston-Smith, M.D., Susan L. Koletar, M.D., Andrew R. Zolopa, M.D., Sangeeta Agarwala, Ph.D., Michael J. Child, B.S., Richard J. Bertz, Ph.D., Lara A. Hosey, M.A., C.C.R.P., David W. Haas, M.D. Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily. Antimicrobial Agents and Chemotherapy. 2007 Sep 01; 51(9):3104-10.

Citation

Scott Evans, Ph.D., Tzu-min Yeh, Ned Sacktor, M.D., David B. Clifford, M.D., David M. Simpson, M.D., Eric N. Miller, Ph.D., Ronald J. Ellis, M.D.,Ph.D., Victor G. Valcour, M.D., Christina M. Marra, M.D., Linda L. Millar, B.S., Giovanni Schifitto, M.D. Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090. HIV Clinical Trials. 2007 Nov 01; 8(6):437-46.

Citation

Kim Keil, M.A., Jill S. Hochreiter, MT, (ASCP), Robin DiFrancesco, M.T., (ASCP), M.B.A., Barry Zingman, M.D., Richard C. Reichman, M.D., Margaret A. Fischl, M.D., Barbara Gripshover, M.D., Gene D. Morse, Pharm.D. Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application. Therapeutic Drug Monitoring. 2007 Feb 01; 29(1):103-9.

Citation

Qing Ma, Ph.D., Alan Forrest, Ph.D., Susan L Rosenkranz, Ph.D., Michael F. Para, M.D., Kevin E. Yarasheski, Ph.D., Richard C. Reichman, M.D., Gene D. Morse, Pharm.D. Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers. Biopharmaceutics & Drug Disposition. 2007 Nov 27; 29(2):91-101.

Citation

Peter T. Frame, M.D., Carl J. Fichtenbaum, M.D. A truvada hypersensitivity reaction simulating abacavir hypersensitivity. AIDS. 2007 Oct 18; 21(16):2252-3.

Citation

Minhee Kang, M.S., Ph.D., Raymond T. Chung, M.D. The role of early viral decline in the treatment of hepatitis C in HIV-1 coinfected persons [Letter to the Editor]. Journal of Acquired Immune Deficiency Syndromes. 2007 Nov 01; 46(3):371-3.